Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021




Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 2, 2021 at 8:00 a.m. ET to announce third quarter 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

Contacts

Investor Contact
Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media Contact
Maureen L. Suda

617-949-4289

maureen.suda@sagerx.com